As a negative control, we also tested HER2 expression on the CD14+ cells of a HER2− luminal type breast cancer patient; no HER2 expression was observed on the CD14+ cells of the luminal type breast cancer patient (Additional file 2: Figure S2A; luminal type tumor). This evidence concerns the gene ERBB2 and neoplasm.